Get the content you want anytime you want.
REGISTER NOW | SIGN IN
The Best Infectious Disease News Delivered Weekly

The Contagion® HIV / AIDS specialty page provides HIV/AIDS-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

HIV / AIDS NEWS - Page 8

Cannabis Use May Reduce HIV-Associated Inflammation & Immune Activation In ART-Treated Patients
A recent study finds a potential link between cannabis use and possible beneficial reduction in systemic inflammation and immune activation in ART-treated HIV patients.
Once-Daily Fixed-Dose HIV Combo Drug from Mylan NV Receives Tentative Approval from FDA
Mylan NV's new drug application for its combo regimen of dolutegravir, emtricitabine, and tenofovir alafenamide, received tentative approval from the US Food and Drug Administration under the President's Emergency Plan for AIDS Relief (PEPFAR).
About Half of Millennials Are Not Getting Tested For HIV
A recent CDC report finds those between 15 and 44 years of age are significantly more likely to have never been tested for HIV.
New Initiatives for HIV Taking Off This Year
Advances in antiretroviral therapies increase opportunities for patients with HIV to have more successful treatment outcomes.
Phase 3 Study to Assess Viral Suppression Capability of 2-Drug ART Regimen
ViiV Healthcare has launched a phase 3 study to assess if adults with HIV-1 who have achieved viral suppression on a 3-drug regimen can maintain suppression when switched to a 2-drug regimen.
Tracing Risk Networks to Identify More Undiagnosed Individuals With HIV
An international research team finds that targeting the social and risk networks of patients recently diagnosed with HIV is leading them to more patients unknowingly infected with the virus.
Top Infectious Disease News of the Week—February 4, 2018
In case you missed them, we've compiled the top five infectious disease articles from this past week.
FDA Approves Another Fixed-Dose HIV-1 Treatment: Symfi Lo Tablets
The FDA approves Symfi Lo Tablets for the treatment of HIV-1 in adult and pediatric patients who weigh at least 35 kg.
FEATURED
The new test can differentiate between Lyme disease and 7 other tick-borne diseases.